triazoles has been researched along with Premature Ejaculation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pyke, RE | 1 |
| Gul, M; Serefoglu, EC | 1 |
| Althof, SE; McMahon, CG; Muirhead, GJ; Osterloh, IH | 1 |
| Atiee, G; Muirhead, GJ; Osterloh, IH; Sultana, S; van den Berg, F; Whaley, S | 1 |
| Muirhead, GJ; Osterloh, IH; van den Berg, F; Whaley, S | 1 |
| Althof, S; Giuliano, F; Harty, B; McMahon, C; Miner, M; Muirhead, GJ; Osterloh, IH; Rosen, R | 1 |
| Althof, S; George, K; Girard, N; Muirhead, GJ; Osterloh, IH | 1 |
4 trial(s) available for triazoles and Premature Ejaculation
| Article | Year |
|---|---|
Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Healthy Volunteers; Humans; Male; Middle Aged; Premature Ejaculation; Pyridines; Receptors, Oxytocin; Treatment Outcome; Triazoles; Young Adult | 2018 |
Pharmacokinetics, Safety, and Tolerability of Multiple Doses of the Novel Oxytocin Receptor Antagonist Cligosiban in Development for Premature Ejaculation: Two Randomized Clinical Trials in Healthy Subjects.
Topics: Administration, Oral; Adolescent; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Middle Aged; Premature Ejaculation; Pyridines; Receptors, Oxytocin; Treatment Outcome; Triazoles; Young Adult | 2019 |
The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).
Topics: Adult; Coitus; Double-Blind Method; Ejaculation; Hormone Antagonists; Humans; Male; Middle Aged; Patient Reported Outcome Measures; Premature Ejaculation; Pyridines; Receptors, Oxytocin; Sexual Behavior; Triazoles | 2019 |
The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).
Topics: Adult; Coitus; Double-Blind Method; Ejaculation; Hormone Antagonists; Humans; Male; Middle Aged; Premature Ejaculation; Pyridines; Receptors, Oxytocin; Sexual Behavior; Treatment Outcome; Triazoles | 2019 |
3 other study(ies) available for triazoles and Premature Ejaculation
| Article | Year |
|---|---|
Cligosiban for Premature Ejaculation: Success, Failure, or Insufficiently Tested?
Topics: Double-Blind Method; Ejaculation; Humans; Male; Oxytocin; Patient Reported Outcome Measures; Premature Ejaculation; Pyridines; Triazoles | 2019 |
Oxytocin antagonists: the next frontier in PE treatment.
Topics: Humans; Male; Oxytocin; Premature Ejaculation; Pyridines; Triazoles | 2019 |
Response to Letter to the Editor Regarding "Cligosiban for Premature Ejaculation: Success, Failure, or Insufficiently Tested?"
Topics: Double-Blind Method; Ejaculation; Humans; Male; Oxytocin; Patient Reported Outcome Measures; Premature Ejaculation; Pyridines; Triazoles | 2019 |